These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24788398)

  • 21. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
    Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
    Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid fine needle aspirate: a post-Bethesda update.
    Bose S; Walts AE
    Adv Anat Pathol; 2012 May; 19(3):160-9. PubMed ID: 22498581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving molecularly targeted therapies for advanced-stage thyroid cancers.
    Bible KC; Ryder M
    Nat Rev Clin Oncol; 2016 Jul; 13(7):403-16. PubMed ID: 26925962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to thyroid cancer.
    Cohen EE
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):255-6. PubMed ID: 22706487
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.
    Filicori F; Keutgen XM; Buitrago D; AlDailami H; Crowley M; Fahey TJ; Zarnegar R
    Surgery; 2011 Dec; 150(6):1085-91. PubMed ID: 22136825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.
    Buryk MA; Monaco SE; Witchel SF; Mehta DK; Gurtunca N; Nikiforov YE; Simons JP
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1697-700. PubMed ID: 23993207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Fundamental Mechanisms of Thyroid Cancer.
    Prete A; Borges de Souza P; Censi S; Muzza M; Nucci N; Sponziello M
    Front Endocrinol (Lausanne); 2020; 11():102. PubMed ID: 32231639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
    Raman P; Koenig RJ
    Nat Rev Endocrinol; 2014 Oct; 10(10):616-23. PubMed ID: 25069464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathology of well-differentiated thyroid carcinomas.
    Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
    Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in studies of the genes related to thyroid carcinoma].
    Zhi JT; Zheng XQ; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):951-955. PubMed ID: 27978891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on molecular biology of thyroid cancers.
    Omur O; Baran Y
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracellular signaling mechanisms in thyroid cancer].
    Mondragón-Terán P; López-Hernández LB; Gutiérrez-Salinas J; Suárez-Cuenca JA; Luna-Ceballos RI; Erazo Valle-Solís A
    Cir Cir; 2016; 84(5):434-43. PubMed ID: 27423883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy: a new hope for thyroid carcinomas.
    Perri F; Pezzullo L; Chiofalo MG; Lastoria S; Di Gennaro F; Scarpati GD; Caponigro F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):55-63. PubMed ID: 25465739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf , ras and pax8 genes.
    Di Cristofaro J; Silvy M; Lanteaume A; Marcy M; Carayon P; De Micco C
    Endocr Relat Cancer; 2006 Jun; 13(2):485-95. PubMed ID: 16728576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncogenes and thyroid tumors].
    Lacroix L; Soria JC; Bidart JM; Schlumberger M
    Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of the PAX8-PPARgamma fusion protein in thyroid tumors.
    Koenig RJ
    Clin Chem; 2010 Mar; 56(3):331-3. PubMed ID: 20075182
    [No Abstract]   [Full Text] [Related]  

  • 40. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
    Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.